28 Aug 2022

DANFLU-1 - High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults

Reported from ESC Congress 2022

Tor Biering-Sørensen talks with Aaysha Cader about the results of the DANFLU-1 trial which were presented during ESC Congress 2022 in Barcelona. In fact, elderly adults who received a high-dose quadrivalent influenza vaccine compared with a standard dose saw significantly reduced risk of death and hospitalization for influenza or pneumonia.